[Therapeutic mechanism of Arctium lappa extract for post-viral pneumonia pulmonary fibrosis: a metabolomics, network pharmacology analysis and experimental verification] [0.03%]
牛蒡子提取物治疗病毒感染后肺纤维化的机制：基于代谢组学、网络药理学分析及实验验证
Guoyong Li,Renling Li,Yiting Liu et al.
Guoyong Li et al.
Objectives: To explore the therapeutic mechanism of Arctium lappa extract for treatment of Post-Viral Pneumonia Pulmonary Fibrosis (PPF). Methods: ...
[Wendan Decoction ameliorates metabolic phenotypes in rats with metabolic syndrome and phlegm syndrome by modulating the gut microbiota-bile acid axis] [0.03%]
温胆汤通过调节肠道菌群-胆汁酸轴改善痰证和代谢综合征大鼠的代谢表型
Kaiyue Huang,Jingxin Qi,Wenqian Luo et al.
Kaiyue Huang et al.
Objectives: To investigate the therapeutic mechanism of Wendan Decoction for phlegm syndrome in rats with metabolic syndrome (MS). Methods: ...
[Down-regulation of ACADM-mediated lipotoxicity inhibits invasion and metastasis of estrogen receptor-positive breast cancer cells] [0.03%]
ACADM介导的脂毒性下调可抑制雌激素受体阳性乳腺癌细胞侵袭和转移
Jiahao Li,Ruiting Xian,Rong Li
Jiahao Li
Objectives: To investigate the effect of downregulation of medium-chain acyl-coenzyme A dehydrogenase (ACADM) on invasion and migration of estrogen receptor-positive breast cancer cells and the underlying mechanism. ...
[Pingchuanning Formula suppresses airway inflammation in a rat model of asthmatic cold syndrome by regulating the HMGB1/Beclin-1 axis-mediated autophagy] [0.03%]
肺炎宁抑制哮喘外感寒证大鼠气道炎症的作用机制研究：调控HMGB1/Beclin-1轴介导的自噬作用
Xinheng Wang,Xiaohan Shao,Tongtong Li et al.
Xinheng Wang et al.
Objectives: To explore the mechanism of Pingchuanning Formula (PCN) for inhibiting airway inflammation in rats with asthmatic cold syndrome. Methods: ...
[Inhibitory effect of Fuzheng Huaji Decoction against non-small cell lung cancer cells in vitro and the possible molecular mechanism] [0.03%]
扶正化积汤体外抑制非小细胞肺癌的作用及可能的分子机制
Lijun He,Xiaofei Chen,Chenxin Yan et al.
Lijun He et al.
Objectives: To investigate the inhibitory effect of Fuzheng Huaji Decoction against non-small cell lung cancer (NSCLC) cells in vitro and explore the underlying mechanism. ...
[ATF3 regulates inflammatory response in atherosclerotic plaques in mice through the NF-κB signaling pathway] [0.03%]
ATF3通过NF-κB信号通路调节小鼠动脉粥样硬化斑块的炎症反应
Bing Xia,Jin Peng,Jiuyang Ding et al.
Bing Xia et al.
Objectives: To investigate the role of activating transcription factor 3 (ATF3) in atherosclerotic plaques for regulating inflammatory responses during atherosclerosis (AS) progression. ...
[Tougu Xiaotong Capsule promotes repair of osteoarthritis cartilage damage in mice by activating the CXCL12/GDF5 pathway] [0.03%]
藤黄小通胶囊通过激活CXCL12/GDF5信号通路促进骨关节炎软骨损伤修复
Changlong Fu,Lu Xu,Ruolan Chen et al.
Changlong Fu et al.
Objectives: To explore the mechanism by which Tougu Xiaotong Capsule (TXC) promotes chondrogenic differentiation and cartilage repair in mice with osteoarthritis (OA). ...
[Toric-ICL shows better predictability and efficacy than FS-LASIK for myopia correction in patients with moderate to high myopia and astigmatism] [0.03%]
[对于中高度近视伴散光患者的屈光矫正 Toric ICL 比 FS-LASIK 更具预测性和有效性]
Hongyang Li,Wenxiong Liao,Peng Lei et al.
Hongyang Li et al.
Objectives: To compare the efficacy of toric implantable collamer lens (Toric-ICL) and femtosecond laser-assisted in situ keratomileusis (FS-LASIK) for myopia correction in patients with moderate to high myopia complicate...
[Biomechanical analysis of a novel bridging plate for treating Rockwood III acromioclavicular joint dislocation] [0.03%]
一种治疗Rockwood三型肩锁关节脱位桥接板的生物力学分析
Yancai Chen,Gaofeng Zhang,Shubo Li et al.
Yancai Chen et al.
Objectives: To assess the biomechanical performance of a novel bridging plate for treating Rockwood III acromioclavicular joint dislocation. Methods: ...
[A comparative study of different methods for treatment switching analysis in clinical trials] [0.03%]
[临床试验中治疗转换分析的不同方法比较研究]
Zhiyue Liang,Lishan Xu,Keke Li et al.
Zhiyue Liang et al.
Objectives: To compare the commonly used methods for analyzing treatment switching in clinical trials to facilitate selection of optimal methods in different scenarios. ...